Rank | Gene Set | Z-score |
---|---|---|
1 | behavioral response to nicotine (GO:0035095) | 5.54721057 |
2 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.80156840 |
3 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.29069082 |
4 | tryptophan catabolic process (GO:0006569) | 4.27340246 |
5 | indole-containing compound catabolic process (GO:0042436) | 4.27340246 |
6 | indolalkylamine catabolic process (GO:0046218) | 4.27340246 |
7 | kynurenine metabolic process (GO:0070189) | 4.21063201 |
8 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.12947552 |
9 | locomotory exploration behavior (GO:0035641) | 4.09667000 |
10 | indolalkylamine metabolic process (GO:0006586) | 3.99758480 |
11 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.95678260 |
12 | fucose catabolic process (GO:0019317) | 3.80980629 |
13 | L-fucose metabolic process (GO:0042354) | 3.80980629 |
14 | L-fucose catabolic process (GO:0042355) | 3.80980629 |
15 | neuron cell-cell adhesion (GO:0007158) | 3.76151243 |
16 | vocalization behavior (GO:0071625) | 3.74981391 |
17 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.72638333 |
18 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.69743821 |
19 | neuronal action potential (GO:0019228) | 3.57079758 |
20 | tryptophan metabolic process (GO:0006568) | 3.51818525 |
21 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.51683379 |
22 | glutamate receptor signaling pathway (GO:0007215) | 3.50001861 |
23 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.43494058 |
24 | serotonin metabolic process (GO:0042428) | 3.41427479 |
25 | cytoplasmic mRNA processing body assembly (GO:0033962) | 3.40217952 |
26 | response to auditory stimulus (GO:0010996) | 3.39982271 |
27 | synaptic transmission, glutamatergic (GO:0035249) | 3.39370361 |
28 | indole-containing compound metabolic process (GO:0042430) | 3.38648399 |
29 | neural tube formation (GO:0001841) | 3.38191765 |
30 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.35930271 |
31 | protein localization to synapse (GO:0035418) | 3.35183515 |
32 | primary amino compound metabolic process (GO:1901160) | 3.34767129 |
33 | regulation of synapse structural plasticity (GO:0051823) | 3.30818200 |
34 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.25459547 |
35 | kidney morphogenesis (GO:0060993) | 3.21117366 |
36 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.20299552 |
37 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 3.19882169 |
38 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.19806931 |
39 | detection of light stimulus involved in visual perception (GO:0050908) | 3.19787525 |
40 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.19787525 |
41 | regulation of hippo signaling (GO:0035330) | 3.18992453 |
42 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.15386154 |
43 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.13088489 |
44 | synaptic vesicle maturation (GO:0016188) | 3.13006435 |
45 | sulfation (GO:0051923) | 3.12702698 |
46 | neuron recognition (GO:0008038) | 3.12405544 |
47 | cellular ketone body metabolic process (GO:0046950) | 3.10578359 |
48 | reflex (GO:0060004) | 3.09575878 |
49 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.09520624 |
50 | microglial cell activation (GO:0001774) | 3.08845882 |
51 | synaptic vesicle exocytosis (GO:0016079) | 3.07560320 |
52 | regulation of synaptic vesicle transport (GO:1902803) | 3.07537131 |
53 | glutamate secretion (GO:0014047) | 3.06409347 |
54 | dendrite morphogenesis (GO:0048813) | 3.05907275 |
55 | nonmotile primary cilium assembly (GO:0035058) | 3.05109085 |
56 | * synaptic vesicle endocytosis (GO:0048488) | 3.02706618 |
57 | exploration behavior (GO:0035640) | 3.00012282 |
58 | regulation of posttranscriptional gene silencing (GO:0060147) | 2.99748493 |
59 | regulation of gene silencing by miRNA (GO:0060964) | 2.99748493 |
60 | regulation of gene silencing by RNA (GO:0060966) | 2.99748493 |
61 | postsynaptic membrane organization (GO:0001941) | 2.99333791 |
62 | startle response (GO:0001964) | 2.97874181 |
63 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.97662190 |
64 | nephron epithelium morphogenesis (GO:0072088) | 2.96954150 |
65 | nephron tubule morphogenesis (GO:0072078) | 2.96954150 |
66 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.96736290 |
67 | neuron-neuron synaptic transmission (GO:0007270) | 2.96714929 |
68 | axonal fasciculation (GO:0007413) | 2.96616203 |
69 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.95569025 |
70 | neuronal action potential propagation (GO:0019227) | 2.95536258 |
71 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 2.95440349 |
72 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.93983303 |
73 | proline transport (GO:0015824) | 2.93549610 |
74 | central nervous system myelination (GO:0022010) | 2.92488662 |
75 | axon ensheathment in central nervous system (GO:0032291) | 2.92488662 |
76 | presynaptic membrane assembly (GO:0097105) | 2.90397159 |
77 | regulation of synapse maturation (GO:0090128) | 2.90250556 |
78 | peristalsis (GO:0030432) | 2.89831067 |
79 | spinal cord motor neuron differentiation (GO:0021522) | 2.88122805 |
80 | layer formation in cerebral cortex (GO:0021819) | 2.86900587 |
81 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.83649119 |
82 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.83649119 |
83 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.83649119 |
84 | cellular potassium ion homeostasis (GO:0030007) | 2.81979566 |
85 | membrane depolarization during action potential (GO:0086010) | 2.81627628 |
86 | positive regulation of insulin-like growth factor receptor signaling pathway (GO:0043568) | 2.80441771 |
87 | auditory behavior (GO:0031223) | 2.79585954 |
88 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.79109019 |
89 | * regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.78313758 |
90 | cell morphogenesis involved in neuron differentiation (GO:0048667) | 2.78127972 |
91 | epithelial cilium movement (GO:0003351) | 2.77867353 |
92 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.77834119 |
93 | NAD biosynthetic process (GO:0009435) | 2.77513008 |
94 | ketone body metabolic process (GO:1902224) | 2.77205934 |
95 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.76892925 |
96 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.76047601 |
97 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.75279230 |
98 | urinary tract smooth muscle contraction (GO:0014848) | 2.75080212 |
99 | cilium movement (GO:0003341) | 2.73701791 |
100 | dendritic spine morphogenesis (GO:0060997) | 2.73595876 |
101 | transmission of nerve impulse (GO:0019226) | 2.72928263 |
102 | cellular biogenic amine catabolic process (GO:0042402) | 2.71513534 |
103 | amine catabolic process (GO:0009310) | 2.71513534 |
104 | G-protein coupled receptor internalization (GO:0002031) | 2.70626145 |
105 | cornea development in camera-type eye (GO:0061303) | 2.69950555 |
106 | regulation of postsynaptic membrane potential (GO:0060078) | 2.69516123 |
107 | L-amino acid import (GO:0043092) | 2.69261342 |
108 | neurotransmitter secretion (GO:0007269) | 2.69092939 |
109 | inner ear receptor stereocilium organization (GO:0060122) | 2.68984138 |
110 | positive regulation of synapse maturation (GO:0090129) | 2.68486921 |
111 | long-term synaptic potentiation (GO:0060291) | 2.68331402 |
112 | long-term memory (GO:0007616) | 2.67935604 |
113 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.67857817 |
114 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.67472012 |
115 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.66336919 |
116 | presynaptic membrane organization (GO:0097090) | 2.65934908 |
117 | signal peptide processing (GO:0006465) | 2.65847147 |
118 | regulation of action potential (GO:0098900) | 2.65514436 |
119 | negative regulation of mast cell activation (GO:0033004) | 2.64725934 |
120 | regulation of neurotransmitter secretion (GO:0046928) | 2.64503883 |
121 | cilium organization (GO:0044782) | 2.64302572 |
122 | membrane depolarization (GO:0051899) | 2.63146906 |
123 | interkinetic nuclear migration (GO:0022027) | 2.62003305 |
124 | action potential (GO:0001508) | 2.60988988 |
125 | cellular response to sterol (GO:0036315) | 2.60732944 |
126 | protein import into peroxisome matrix (GO:0016558) | 2.59712555 |
127 | atrial cardiac muscle cell action potential (GO:0086014) | 2.59297131 |
128 | cilium assembly (GO:0042384) | 2.57934443 |
129 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.56999526 |
130 | cAMP catabolic process (GO:0006198) | 2.55870355 |
131 | gamma-aminobutyric acid transport (GO:0015812) | 2.53906559 |
132 | amino acid import (GO:0043090) | 2.52667420 |
133 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.51882239 |
134 | retinal cone cell development (GO:0046549) | 2.51453366 |
135 | innervation (GO:0060384) | 2.50535780 |
136 | negative regulation of sodium ion transport (GO:0010766) | 2.50146569 |
137 | response to pheromone (GO:0019236) | 2.49935627 |
138 | glycine transport (GO:0015816) | 2.49706385 |
139 | regulation of synaptic plasticity (GO:0048167) | 2.49563060 |
140 | renal tubule morphogenesis (GO:0061333) | 2.49238015 |
141 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213) | 2.48760920 |
142 | regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211) | 2.48760920 |
143 | auditory receptor cell stereocilium organization (GO:0060088) | 2.48717226 |
144 | benzene-containing compound metabolic process (GO:0042537) | 2.48646376 |
145 | cilium morphogenesis (GO:0060271) | 2.48409620 |
146 | neurotransmitter metabolic process (GO:0042133) | 2.48121647 |
147 | regulation of respiratory system process (GO:0044065) | 2.47621888 |
148 | oxidative demethylation (GO:0070989) | 2.47387935 |
149 | cardiovascular system development (GO:0072358) | 2.47249333 |
150 | detection of mechanical stimulus involved in sensory perception (GO:0050974) | 2.46813637 |
151 | phasic smooth muscle contraction (GO:0014821) | 2.46538982 |
152 | cell differentiation in spinal cord (GO:0021515) | 2.46382644 |
153 | cerebellar granule cell differentiation (GO:0021707) | 2.46235922 |
154 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.46222465 |
155 | somite rostral/caudal axis specification (GO:0032525) | 2.45119007 |
156 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.44987675 |
157 | synapse assembly (GO:0007416) | 2.44828058 |
158 | neuromuscular process controlling balance (GO:0050885) | 2.44771459 |
159 | negative regulation of dendrite development (GO:2000171) | 2.44706239 |
160 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.44112131 |
161 | activation of protein kinase A activity (GO:0034199) | 2.43863901 |
162 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.43491775 |
163 | neuronal stem cell maintenance (GO:0097150) | 2.42513593 |
164 | rRNA catabolic process (GO:0016075) | 2.41924347 |
165 | regulation of dendritic spine development (GO:0060998) | 2.41433266 |
166 | behavioral defense response (GO:0002209) | 2.41372334 |
167 | behavioral fear response (GO:0001662) | 2.41372334 |
168 | N-glycan processing (GO:0006491) | 2.39471142 |
169 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.37025631 |
170 | chondroitin sulfate catabolic process (GO:0030207) | 2.36266882 |
171 | adult walking behavior (GO:0007628) | 2.35453081 |
172 | axon extension (GO:0048675) | 2.35103686 |
173 | regulation of neurotransmitter transport (GO:0051588) | 2.34347418 |
174 | membrane hyperpolarization (GO:0060081) | 2.34328611 |
175 | positive regulation of synaptic transmission (GO:0050806) | 2.33688300 |
176 | fear response (GO:0042596) | 2.33190615 |
177 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.33106837 |
178 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.30677957 |
179 | neurotransmitter transport (GO:0006836) | 2.30575344 |
180 | neuronal ion channel clustering (GO:0045161) | 2.29320267 |
181 | learning (GO:0007612) | 2.29225344 |
182 | behavioral response to ethanol (GO:0048149) | 2.29021459 |
183 | positive regulation of dendritic spine development (GO:0060999) | 2.28317993 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.50670623 |
2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.72563662 |
3 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.61121710 |
4 | VDR_22108803_ChIP-Seq_LS180_Human | 2.94082651 |
5 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.54450109 |
6 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.50448374 |
7 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.47927830 |
8 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.33189365 |
9 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.26872038 |
10 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.25312253 |
11 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.25312253 |
12 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.20400505 |
13 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.17261415 |
14 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.15874753 |
15 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.09205160 |
16 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.06813883 |
17 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.06014789 |
18 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.05727778 |
19 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.05275039 |
20 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.94078782 |
21 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.91075451 |
22 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.85695487 |
23 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.84419106 |
24 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.84148206 |
25 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.84049118 |
26 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.82526682 |
27 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.80271203 |
28 | EWS_26573619_Chip-Seq_HEK293_Human | 1.79655299 |
29 | FUS_26573619_Chip-Seq_HEK293_Human | 1.76499245 |
30 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.70758896 |
31 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.67228453 |
32 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.65816249 |
33 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.65502914 |
34 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.63675211 |
35 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.59874750 |
36 | P300_19829295_ChIP-Seq_ESCs_Human | 1.59479698 |
37 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.58621172 |
38 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.57523563 |
39 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.57482910 |
40 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.55081299 |
41 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.54282839 |
42 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.52932983 |
43 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.50941224 |
44 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.49342396 |
45 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.46713679 |
46 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.44984878 |
47 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.44821289 |
48 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.43599451 |
49 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.41844275 |
50 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.40381250 |
51 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.40081790 |
52 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.39909600 |
53 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.39787049 |
54 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.39685044 |
55 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.39678299 |
56 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.38975835 |
57 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.38060266 |
58 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.37869682 |
59 | STAT3_23295773_ChIP-Seq_U87_Human | 1.36664215 |
60 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.34309210 |
61 | AR_25329375_ChIP-Seq_VCAP_Human | 1.34116793 |
62 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.31253482 |
63 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.29709863 |
64 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.29246974 |
65 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.28894056 |
66 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.28290750 |
67 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.28290750 |
68 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.27969610 |
69 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.27969610 |
70 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.27934649 |
71 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.25276044 |
72 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.25210251 |
73 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.24842252 |
74 | TP53_16413492_ChIP-PET_HCT116_Human | 1.24718551 |
75 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.23578544 |
76 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.23355481 |
77 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.21300403 |
78 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.20526977 |
79 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.20431298 |
80 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.18616511 |
81 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.18526038 |
82 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.17725025 |
83 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.17021243 |
84 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.16656048 |
85 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.15911600 |
86 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.14719694 |
87 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.14508388 |
88 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.14429537 |
89 | * AR_19668381_ChIP-Seq_PC3_Human | 1.14307190 |
90 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.14304540 |
91 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.13789172 |
92 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.13136913 |
93 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.12054149 |
94 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.11982863 |
95 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.11785785 |
96 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.10783731 |
97 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.10772599 |
98 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.10772599 |
99 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.09199359 |
100 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.07812426 |
101 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.07615108 |
102 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.06301901 |
103 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.06235888 |
104 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.05752808 |
105 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.05172412 |
106 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.05117582 |
107 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.04671985 |
108 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.04668865 |
109 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.04578966 |
110 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.03584450 |
111 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.03583316 |
112 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.03583316 |
113 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.03298282 |
114 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.03283182 |
115 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.02801720 |
116 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.02705656 |
117 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.02677531 |
118 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.02492754 |
119 | RXR_22108803_ChIP-Seq_LS180_Human | 1.02365676 |
120 | KDM2B_26808549_Chip-Seq_REH_Human | 1.01905303 |
121 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.01667196 |
122 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.01588866 |
123 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.00552814 |
124 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.00388347 |
125 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.00027083 |
126 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99649167 |
127 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.98840718 |
128 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.97908791 |
129 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.96509578 |
130 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.96264676 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004859_abnormal_synaptic_plasticity | 5.20163201 |
2 | MP0003880_abnormal_central_pattern | 3.46855707 |
3 | * MP0003635_abnormal_synaptic_transmissio | 3.29340099 |
4 | MP0003136_yellow_coat_color | 3.18677128 |
5 | MP0001968_abnormal_touch/_nociception | 2.93742769 |
6 | * MP0002063_abnormal_learning/memory/cond | 2.69899503 |
7 | MP0009046_muscle_twitch | 2.68858107 |
8 | MP0009745_abnormal_behavioral_response | 2.64513488 |
9 | MP0002064_seizures | 2.61512426 |
10 | MP0004270_analgesia | 2.59065379 |
11 | MP0002736_abnormal_nociception_after | 2.58674602 |
12 | MP0003195_calcinosis | 2.56235639 |
13 | * MP0002572_abnormal_emotion/affect_behav | 2.47290995 |
14 | MP0001486_abnormal_startle_reflex | 2.46244992 |
15 | MP0002734_abnormal_mechanical_nocicepti | 2.25580130 |
16 | MP0005423_abnormal_somatic_nervous | 2.25146439 |
17 | MP0000778_abnormal_nervous_system | 2.21399247 |
18 | MP0004043_abnormal_pH_regulation | 2.20733127 |
19 | MP0002653_abnormal_ependyma_morphology | 2.13229012 |
20 | MP0003646_muscle_fatigue | 2.12360357 |
21 | MP0009780_abnormal_chondrocyte_physiolo | 2.08330121 |
22 | MP0000569_abnormal_digit_pigmentation | 2.06105450 |
23 | MP0002272_abnormal_nervous_system | 2.05271026 |
24 | MP0001984_abnormal_olfaction | 1.99555080 |
25 | MP0002067_abnormal_sensory_capabilities | 1.98345637 |
26 | MP0005645_abnormal_hypothalamus_physiol | 1.94524049 |
27 | MP0001440_abnormal_grooming_behavior | 1.94083873 |
28 | MP0003787_abnormal_imprinting | 1.93974701 |
29 | MP0001501_abnormal_sleep_pattern | 1.93463160 |
30 | MP0005646_abnormal_pituitary_gland | 1.83625343 |
31 | * MP0002557_abnormal_social/conspecific_i | 1.83250835 |
32 | MP0001188_hyperpigmentation | 1.81623943 |
33 | MP0002184_abnormal_innervation | 1.78539657 |
34 | MP0003283_abnormal_digestive_organ | 1.78114944 |
35 | MP0003890_abnormal_embryonic-extraembry | 1.74329844 |
36 | MP0004858_abnormal_nervous_system | 1.72974609 |
37 | MP0001970_abnormal_pain_threshold | 1.72942030 |
38 | MP0002735_abnormal_chemical_nociception | 1.72787758 |
39 | MP0002733_abnormal_thermal_nociception | 1.72361690 |
40 | MP0000427_abnormal_hair_cycle | 1.71623325 |
41 | MP0004133_heterotaxia | 1.69543520 |
42 | MP0008872_abnormal_physiological_respon | 1.68139639 |
43 | MP0008877_abnormal_DNA_methylation | 1.65368871 |
44 | MP0003183_abnormal_peptide_metabolism | 1.63342093 |
45 | MP0006276_abnormal_autonomic_nervous | 1.54668579 |
46 | MP0005670_abnormal_white_adipose | 1.54186977 |
47 | MP0006292_abnormal_olfactory_placode | 1.52415547 |
48 | MP0004885_abnormal_endolymph | 1.51978486 |
49 | MP0003690_abnormal_glial_cell | 1.51453576 |
50 | MP0000383_abnormal_hair_follicle | 1.50453554 |
51 | MP0002938_white_spotting | 1.49985072 |
52 | MP0005253_abnormal_eye_physiology | 1.44810668 |
53 | MP0008569_lethality_at_weaning | 1.41507626 |
54 | MP0005171_absent_coat_pigmentation | 1.39555514 |
55 | MP0008875_abnormal_xenobiotic_pharmacok | 1.38773783 |
56 | MP0005409_darkened_coat_color | 1.36064837 |
57 | MP0000516_abnormal_urinary_system | 1.35733078 |
58 | MP0005367_renal/urinary_system_phenotyp | 1.35733078 |
59 | MP0004811_abnormal_neuron_physiology | 1.33140380 |
60 | MP0002837_dystrophic_cardiac_calcinosis | 1.31433263 |
61 | MP0003172_abnormal_lysosome_physiology | 1.30747184 |
62 | MP0003633_abnormal_nervous_system | 1.29996426 |
63 | MP0002638_abnormal_pupillary_reflex | 1.28251202 |
64 | MP0001502_abnormal_circadian_rhythm | 1.28215191 |
65 | MP0003045_fibrosis | 1.26988299 |
66 | MP0002822_catalepsy | 1.26805993 |
67 | MP0005174_abnormal_tail_pigmentation | 1.23773189 |
68 | MP0001177_atelectasis | 1.22880200 |
69 | * MP0002882_abnormal_neuron_morphology | 1.22521954 |
70 | MP0008961_abnormal_basal_metabolism | 1.21162872 |
71 | MP0002928_abnormal_bile_duct | 1.20290206 |
72 | MP0003137_abnormal_impulse_conducting | 1.19183914 |
73 | MP0004742_abnormal_vestibular_system | 1.16578202 |
74 | * MP0005386_behavior/neurological_phenoty | 1.15971144 |
75 | * MP0004924_abnormal_behavior | 1.15971144 |
76 | MP0001986_abnormal_taste_sensitivity | 1.14420498 |
77 | * MP0002066_abnormal_motor_capabilities/c | 1.12875941 |
78 | MP0000955_abnormal_spinal_cord | 1.12865680 |
79 | MP0001529_abnormal_vocalization | 1.10816618 |
80 | MP0002909_abnormal_adrenal_gland | 1.09947461 |
81 | MP0003119_abnormal_digestive_system | 1.09640989 |
82 | MP0003878_abnormal_ear_physiology | 1.09563939 |
83 | MP0005377_hearing/vestibular/ear_phenot | 1.09563939 |
84 | MP0003634_abnormal_glial_cell | 1.09337416 |
85 | MP0006072_abnormal_retinal_apoptosis | 1.08819971 |
86 | MP0004484_altered_response_of | 1.08160460 |
87 | MP0005195_abnormal_posterior_eye | 1.05914318 |
88 | MP0004142_abnormal_muscle_tone | 1.05825531 |
89 | MP0001905_abnormal_dopamine_level | 1.04966175 |
90 | * MP0002152_abnormal_brain_morphology | 1.02554898 |
91 | MP0000230_abnormal_systemic_arterial | 1.01906760 |
92 | MP0001963_abnormal_hearing_physiology | 1.01827234 |
93 | MP0004145_abnormal_muscle_electrophysio | 1.01647473 |
94 | MP0000015_abnormal_ear_pigmentation | 0.99639582 |
95 | MP0003631_nervous_system_phenotype | 0.97586008 |
96 | MP0003011_delayed_dark_adaptation | 0.95569062 |
97 | MP0005187_abnormal_penis_morphology | 0.92862135 |
98 | MP0002090_abnormal_vision | 0.92377103 |
99 | MP0005394_taste/olfaction_phenotype | 0.91777712 |
100 | MP0005499_abnormal_olfactory_system | 0.91777712 |
101 | MP0001299_abnormal_eye_distance/ | 0.89470632 |
102 | MP0002160_abnormal_reproductive_system | 0.88501540 |
103 | MP0000538_abnormal_urinary_bladder | 0.88451568 |
104 | MP0003122_maternal_imprinting | 0.87777897 |
105 | MP0000631_abnormal_neuroendocrine_gland | 0.86530410 |
106 | MP0005085_abnormal_gallbladder_physiolo | 0.84900289 |
107 | MP0003937_abnormal_limbs/digits/tail_de | 0.84356753 |
108 | MP0002751_abnormal_autonomic_nervous | 0.82809544 |
109 | MP0005257_abnormal_intraocular_pressure | 0.82740172 |
110 | MP0005448_abnormal_energy_balance | 0.82034670 |
111 | MP0000566_synostosis | 0.81568185 |
112 | MP0005167_abnormal_blood-brain_barrier | 0.81325566 |
113 | MP0002277_abnormal_respiratory_mucosa | 0.81304091 |
114 | MP0004130_abnormal_muscle_cell | 0.80911454 |
115 | MP0000647_abnormal_sebaceous_gland | 0.79923097 |
116 | MP0003959_abnormal_lean_body | 0.79816122 |
117 | MP0003252_abnormal_bile_duct | 0.79737897 |
118 | MP0002095_abnormal_skin_pigmentation | 0.79162884 |
119 | MP0002752_abnormal_somatic_nervous | 0.78957984 |
120 | MP0003638_abnormal_response/metabolism_ | 0.78447628 |
121 | MP0003879_abnormal_hair_cell | 0.78196447 |
122 | MP0000026_abnormal_inner_ear | 0.77799257 |
123 | MP0004085_abnormal_heartbeat | 0.76452921 |
124 | MP0002069_abnormal_eating/drinking_beha | 0.76325060 |
125 | MP0008874_decreased_physiological_sensi | 0.76062111 |
126 | MP0002229_neurodegeneration | 0.73103378 |
127 | MP0002102_abnormal_ear_morphology | 0.72308772 |
128 | MP0005666_abnormal_adipose_tissue | 0.71182734 |
129 | MP0004215_abnormal_myocardial_fiber | 0.70423746 |
130 | MP0003632_abnormal_nervous_system | 0.69360117 |
131 | MP0000013_abnormal_adipose_tissue | 0.69090081 |
132 | MP0010386_abnormal_urinary_bladder | 0.68944874 |
133 | MP0000751_myopathy | 0.67262162 |
134 | MP0002876_abnormal_thyroid_physiology | 0.65852964 |
135 | MP0000920_abnormal_myelination | 0.63750125 |
136 | MP0005623_abnormal_meninges_morphology | 0.63012541 |
137 | * MP0003861_abnormal_nervous_system | 0.62704647 |
138 | MP0002234_abnormal_pharynx_morphology | 0.61916887 |
139 | MP0003938_abnormal_ear_development | 0.59448746 |
140 | MP0004147_increased_porphyrin_level | 0.59192939 |
141 | MP0001485_abnormal_pinna_reflex | 0.59032586 |
142 | MP0005551_abnormal_eye_electrophysiolog | 0.56480767 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Focal motor seizures (HP:0011153) | 5.47391102 |
2 | Birth length less than 3rd percentile (HP:0003561) | 5.28306741 |
3 | Pancreatic cysts (HP:0001737) | 4.53279890 |
4 | True hermaphroditism (HP:0010459) | 4.34550284 |
5 | Pancreatic fibrosis (HP:0100732) | 4.26021070 |
6 | Febrile seizures (HP:0002373) | 4.22033282 |
7 | Abnormality of midbrain morphology (HP:0002418) | 4.10760811 |
8 | Molar tooth sign on MRI (HP:0002419) | 4.10760811 |
9 | Focal seizures (HP:0007359) | 4.01693079 |
10 | Epileptic encephalopathy (HP:0200134) | 3.78068330 |
11 | Congenital stationary night blindness (HP:0007642) | 3.65176931 |
12 | Supranuclear gaze palsy (HP:0000605) | 3.56809705 |
13 | Type II lissencephaly (HP:0007260) | 3.52018241 |
14 | Myokymia (HP:0002411) | 3.51077343 |
15 | Progressive cerebellar ataxia (HP:0002073) | 3.34258078 |
16 | Inability to walk (HP:0002540) | 3.29998681 |
17 | Action tremor (HP:0002345) | 3.29245330 |
18 | Atonic seizures (HP:0010819) | 3.27291945 |
19 | Patellar aplasia (HP:0006443) | 3.21736015 |
20 | Breast hypoplasia (HP:0003187) | 3.11079789 |
21 | Poor eye contact (HP:0000817) | 3.08712160 |
22 | Abnormality of the renal cortex (HP:0011035) | 3.07979718 |
23 | Abnormality of the renal medulla (HP:0100957) | 3.04695411 |
24 | Cystic liver disease (HP:0006706) | 3.04609546 |
25 | Large for gestational age (HP:0001520) | 3.04304597 |
26 | Broad-based gait (HP:0002136) | 3.03802320 |
27 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.98474978 |
28 | Postural instability (HP:0002172) | 2.97001272 |
29 | Drooling (HP:0002307) | 2.95704873 |
30 | Excessive salivation (HP:0003781) | 2.95704873 |
31 | Congenital, generalized hypertrichosis (HP:0004540) | 2.93746904 |
32 | Visual hallucinations (HP:0002367) | 2.93561746 |
33 | Progressive inability to walk (HP:0002505) | 2.90922841 |
34 | Mutism (HP:0002300) | 2.86875709 |
35 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.85027893 |
36 | Abnormality of alanine metabolism (HP:0010916) | 2.85027893 |
37 | Hyperalaninemia (HP:0003348) | 2.85027893 |
38 | Medial flaring of the eyebrow (HP:0010747) | 2.82444879 |
39 | Attenuation of retinal blood vessels (HP:0007843) | 2.82132398 |
40 | Chronic hepatic failure (HP:0100626) | 2.81501527 |
41 | Tubular atrophy (HP:0000092) | 2.78108212 |
42 | Hyperventilation (HP:0002883) | 2.73691152 |
43 | Arterial tortuosity (HP:0005116) | 2.69650499 |
44 | Furrowed tongue (HP:0000221) | 2.67586918 |
45 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.65684209 |
46 | Generalized tonic-clonic seizures (HP:0002069) | 2.63418809 |
47 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.61898829 |
48 | Abnormal social behavior (HP:0012433) | 2.61802025 |
49 | Impaired social interactions (HP:0000735) | 2.61802025 |
50 | Generalized hypopigmentation of hair (HP:0011358) | 2.59749630 |
51 | Aqueductal stenosis (HP:0002410) | 2.57931224 |
52 | Lissencephaly (HP:0001339) | 2.57479112 |
53 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.57296176 |
54 | Sclerocornea (HP:0000647) | 2.52915490 |
55 | Retinal atrophy (HP:0001105) | 2.50028098 |
56 | Absence seizures (HP:0002121) | 2.49895597 |
57 | Aplasia involving bones of the extremities (HP:0009825) | 2.49615152 |
58 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.49615152 |
59 | Aplasia of the phalanges of the hand (HP:0009802) | 2.49615152 |
60 | Cerebellar dysplasia (HP:0007033) | 2.49604876 |
61 | Gait imbalance (HP:0002141) | 2.48543304 |
62 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.47100576 |
63 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.47100576 |
64 | Abnormality of glycolipid metabolism (HP:0010969) | 2.47100576 |
65 | Increased corneal curvature (HP:0100692) | 2.44306052 |
66 | Keratoconus (HP:0000563) | 2.44306052 |
67 | Abolished electroretinogram (ERG) (HP:0000550) | 2.43716092 |
68 | Hypoplastic ischia (HP:0003175) | 2.42415852 |
69 | Diplopia (HP:0000651) | 2.42079066 |
70 | Abnormality of binocular vision (HP:0011514) | 2.42079066 |
71 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.41838018 |
72 | Vascular tortuosity (HP:0004948) | 2.39573190 |
73 | Concave nail (HP:0001598) | 2.37728208 |
74 | Exotropia (HP:0000577) | 2.35641275 |
75 | Abnormality of salivation (HP:0100755) | 2.35122791 |
76 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.33712525 |
77 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.33712525 |
78 | Dialeptic seizures (HP:0011146) | 2.32010549 |
79 | Genetic anticipation (HP:0003743) | 2.31729202 |
80 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.31408715 |
81 | Obstructive sleep apnea (HP:0002870) | 2.29868586 |
82 | Congenital primary aphakia (HP:0007707) | 2.29590643 |
83 | Hemiparesis (HP:0001269) | 2.29314764 |
84 | Abnormality of secondary sexual hair (HP:0009888) | 2.28418426 |
85 | Abnormality of the axillary hair (HP:0100134) | 2.28418426 |
86 | Congenital sensorineural hearing impairment (HP:0008527) | 2.27808658 |
87 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.26675657 |
88 | Male pseudohermaphroditism (HP:0000037) | 2.26198413 |
89 | Absent speech (HP:0001344) | 2.25929983 |
90 | Pendular nystagmus (HP:0012043) | 2.23669467 |
91 | Anencephaly (HP:0002323) | 2.22152353 |
92 | Decreased circulating renin level (HP:0003351) | 2.21928969 |
93 | Hypoplastic labia majora (HP:0000059) | 2.20845158 |
94 | Abnormality of the ischium (HP:0003174) | 2.20650196 |
95 | Abnormal eating behavior (HP:0100738) | 2.20041843 |
96 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.19935167 |
97 | Widely spaced teeth (HP:0000687) | 2.18166992 |
98 | Congenital hepatic fibrosis (HP:0002612) | 2.17662292 |
99 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.17080449 |
100 | Absent/shortened dynein arms (HP:0200106) | 2.17080449 |
101 | Gaze-evoked nystagmus (HP:0000640) | 2.16437666 |
102 | Renal cortical cysts (HP:0000803) | 2.15381124 |
103 | Retinal dysplasia (HP:0007973) | 2.14420179 |
104 | Polydipsia (HP:0001959) | 2.13705737 |
105 | Abnormal drinking behavior (HP:0030082) | 2.13705737 |
106 | Blue irides (HP:0000635) | 2.11967789 |
107 | Thyroid-stimulating hormone excess (HP:0002925) | 2.10731073 |
108 | Abnormal ciliary motility (HP:0012262) | 2.09470942 |
109 | Gastroesophageal reflux (HP:0002020) | 2.07628265 |
110 | Bronchomalacia (HP:0002780) | 2.06943438 |
111 | Nephrogenic diabetes insipidus (HP:0009806) | 2.05572053 |
112 | Hemiplegia (HP:0002301) | 2.03383589 |
113 | Abnormality of the labia majora (HP:0012881) | 2.02941827 |
114 | Clumsiness (HP:0002312) | 2.02658098 |
115 | Urethral obstruction (HP:0000796) | 2.02096747 |
116 | Inappropriate behavior (HP:0000719) | 2.01416877 |
117 | Megalencephaly (HP:0001355) | 2.01026081 |
118 | Chorioretinal atrophy (HP:0000533) | 2.00937004 |
119 | Genital tract atresia (HP:0001827) | 2.00846655 |
120 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.99810900 |
121 | Global brain atrophy (HP:0002283) | 1.99035309 |
122 | Decreased central vision (HP:0007663) | 1.96420391 |
123 | Abnormality of the nasal septum (HP:0000419) | 1.96023439 |
124 | Limb dystonia (HP:0002451) | 1.95179718 |
125 | Dysdiadochokinesis (HP:0002075) | 1.94472636 |
126 | Vaginal atresia (HP:0000148) | 1.94414186 |
127 | Impaired smooth pursuit (HP:0007772) | 1.94006094 |
128 | Optic nerve hypoplasia (HP:0000609) | 1.93178353 |
129 | Neurofibrillary tangles (HP:0002185) | 1.90320661 |
130 | Depression (HP:0000716) | 1.90219022 |
131 | Truncal ataxia (HP:0002078) | 1.88985681 |
132 | Protruding tongue (HP:0010808) | 1.88738337 |
133 | Preaxial foot polydactyly (HP:0001841) | 1.88604616 |
134 | Spastic tetraparesis (HP:0001285) | 1.87688805 |
135 | Abnormality of the pubic bones (HP:0003172) | 1.86611923 |
136 | Postaxial foot polydactyly (HP:0001830) | 1.86005767 |
137 | Bradycardia (HP:0001662) | 1.85109006 |
138 | Fair hair (HP:0002286) | 1.83525886 |
139 | Poor coordination (HP:0002370) | 1.82313978 |
140 | Oligodactyly (hands) (HP:0001180) | 1.81602663 |
141 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.81246698 |
142 | Polyphagia (HP:0002591) | 1.78702469 |
143 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.78403384 |
144 | Abnormality of the pons (HP:0007361) | 1.78392556 |
145 | Mesangial abnormality (HP:0001966) | 1.78001686 |
146 | Stereotypic behavior (HP:0000733) | 1.77815502 |
147 | Bile duct proliferation (HP:0001408) | 1.76944689 |
148 | Abnormal biliary tract physiology (HP:0012439) | 1.76944689 |
149 | Insidious onset (HP:0003587) | 1.75546573 |
150 | Termporal pattern (HP:0011008) | 1.75546573 |
151 | Neuronal loss in central nervous system (HP:0002529) | 1.74854746 |
152 | Dysmetria (HP:0001310) | 1.74395040 |
153 | Prolonged QT interval (HP:0001657) | 1.74337243 |
154 | Systemic lupus erythematosus (HP:0002725) | 1.74187130 |
155 | Cerebral aneurysm (HP:0004944) | 1.73467550 |
156 | Abnormal EKG (HP:0003115) | 1.72287644 |
157 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.71337675 |
158 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.71237510 |
159 | Ulnar claw (HP:0001178) | 1.70876275 |
160 | Intention tremor (HP:0002080) | 1.70156960 |
161 | Hip dysplasia (HP:0001385) | 1.65355455 |
162 | Status epilepticus (HP:0002133) | 1.64647747 |
163 | Elfin facies (HP:0004428) | 1.63777389 |
164 | Lower limb asymmetry (HP:0100559) | 1.63002662 |
165 | Narrow nasal bridge (HP:0000446) | 1.61512045 |
166 | Anxiety (HP:0000739) | 1.61381160 |
167 | Agitation (HP:0000713) | 1.60849028 |
168 | Palpebral edema (HP:0100540) | 1.60810719 |
169 | Dysostosis multiplex (HP:0000943) | 1.59398031 |
170 | Submucous cleft hard palate (HP:0000176) | 1.59348764 |
171 | Lower limb muscle weakness (HP:0007340) | 1.59252722 |
172 | Amblyopia (HP:0000646) | 1.58447247 |
173 | Nephronophthisis (HP:0000090) | 1.55561792 |
174 | Midline defect of the nose (HP:0004122) | 1.53723460 |
175 | Fetal akinesia sequence (HP:0001989) | 1.53269426 |
176 | * Deeply set eye (HP:0000490) | 1.53111178 |
177 | Limited hip movement (HP:0008800) | 1.52966860 |
Rank | Gene Set | Z-score |
---|---|---|
1 | FRK | 6.83663494 |
2 | NTRK3 | 4.11074802 |
3 | ACVR1B | 3.53180916 |
4 | EPHA4 | 3.30689264 |
5 | MAP3K4 | 2.99610106 |
6 | CASK | 2.97445633 |
7 | MARK1 | 2.61384888 |
8 | TNIK | 2.57032475 |
9 | NTRK2 | 2.49807939 |
10 | MAP2K7 | 2.46765215 |
11 | WNK3 | 2.33431012 |
12 | WNK4 | 2.22183682 |
13 | MAPK13 | 2.02586236 |
14 | GRK1 | 1.97815587 |
15 | TGFBR2 | 1.97368711 |
16 | CDK3 | 1.94893537 |
17 | CAMK1G | 1.92737859 |
18 | ZAK | 1.85853585 |
19 | MAP3K9 | 1.83378586 |
20 | TGFBR1 | 1.75056288 |
21 | RIPK4 | 1.73706368 |
22 | MAP2K4 | 1.67949233 |
23 | INSRR | 1.65306571 |
24 | MINK1 | 1.65143675 |
25 | SGK2 | 1.54287681 |
26 | MKNK2 | 1.49956830 |
27 | WEE1 | 1.48136800 |
28 | GRK7 | 1.47191058 |
29 | CAMK1D | 1.46801328 |
30 | LMTK2 | 1.45422228 |
31 | MAP3K6 | 1.43584403 |
32 | DAPK2 | 1.43063785 |
33 | TAOK3 | 1.42832983 |
34 | PHKG1 | 1.35340572 |
35 | PHKG2 | 1.35340572 |
36 | BMPR1B | 1.31238950 |
37 | OXSR1 | 1.29587123 |
38 | SGK223 | 1.27132949 |
39 | SGK494 | 1.27132949 |
40 | SIK2 | 1.27001709 |
41 | PRKD3 | 1.24019431 |
42 | FES | 1.23886986 |
43 | STK39 | 1.23526916 |
44 | CAMKK2 | 1.20221964 |
45 | MAP4K2 | 1.19660595 |
46 | PAK6 | 1.18822743 |
47 | SGK3 | 1.15498039 |
48 | CAMKK1 | 1.13163147 |
49 | ADRBK2 | 1.12830132 |
50 | PLK2 | 1.12591005 |
51 | PINK1 | 1.11559246 |
52 | STK38 | 1.07640745 |
53 | MAPK15 | 1.05107796 |
54 | CDK5 | 1.02288206 |
55 | TLK1 | 1.01449103 |
56 | BMPR2 | 0.97547268 |
57 | GRK5 | 0.96518973 |
58 | ERBB3 | 0.95981279 |
59 | PAK3 | 0.94543507 |
60 | FGR | 0.89372799 |
61 | NEK2 | 0.89088178 |
62 | MAPKAPK3 | 0.88703910 |
63 | IRAK2 | 0.87047621 |
64 | WNK1 | 0.85210938 |
65 | NTRK1 | 0.84511730 |
66 | PRKCG | 0.83254709 |
67 | CAMK2A | 0.82186844 |
68 | STK38L | 0.81825916 |
69 | FER | 0.81627285 |
70 | PNCK | 0.80994801 |
71 | KSR1 | 0.80032799 |
72 | SGK1 | 0.78457463 |
73 | LATS1 | 0.77573952 |
74 | MAP3K12 | 0.73501431 |
75 | PRKCE | 0.73102469 |
76 | MAPK12 | 0.73034067 |
77 | CAMK1 | 0.72650312 |
78 | PTK2B | 0.70993745 |
79 | CAMK4 | 0.70661992 |
80 | RET | 0.69184804 |
81 | NEK6 | 0.69103954 |
82 | STK11 | 0.68694080 |
83 | DYRK1A | 0.67858320 |
84 | MARK2 | 0.67020640 |
85 | MKNK1 | 0.66763595 |
86 | DYRK2 | 0.66531961 |
87 | MAPKAPK5 | 0.65731224 |
88 | PRKCH | 0.64640627 |
89 | LATS2 | 0.64149844 |
90 | TYRO3 | 0.62787863 |
91 | BRSK2 | 0.57945497 |
92 | RPS6KA5 | 0.57538376 |
93 | CHUK | 0.56938891 |
94 | IRAK3 | 0.56919857 |
95 | DMPK | 0.55942433 |
96 | CAMK2B | 0.54755765 |
97 | PKN1 | 0.54594041 |
98 | RPS6KA2 | 0.52652475 |
99 | OBSCN | 0.52159709 |
100 | PRKG1 | 0.51183765 |
101 | MAP2K1 | 0.50852459 |
102 | PRPF4B | 0.50481356 |
103 | MAPK7 | 0.50144138 |
104 | TRPM7 | 0.49654232 |
105 | ERBB2 | 0.49188663 |
106 | NUAK1 | 0.48993801 |
107 | RPS6KA6 | 0.48263329 |
108 | KSR2 | 0.48243043 |
109 | MAP3K13 | 0.46540249 |
110 | IGF1R | 0.46208523 |
111 | PRKACA | 0.45289277 |
112 | PIK3CA | 0.45076445 |
113 | TIE1 | 0.44538475 |
114 | MAP2K6 | 0.43942982 |
115 | TXK | 0.43738192 |
116 | RPS6KA3 | 0.43276904 |
117 | CSNK1G2 | 0.42061852 |
118 | NEK9 | 0.41334878 |
119 | FYN | 0.40579990 |
120 | EPHB2 | 0.39864472 |
121 | DAPK1 | 0.39728164 |
122 | MAPK10 | 0.38216593 |
123 | AKT3 | 0.37205886 |
124 | CHEK2 | 0.36535542 |
125 | PRKCQ | 0.36244909 |
126 | PIK3CG | 0.36189142 |
127 | MUSK | 0.35091154 |
128 | CDC42BPA | 0.34878020 |
129 | PRKAA1 | 0.34410510 |
130 | PDK2 | 0.34403761 |
131 | MAP3K7 | 0.33945087 |
132 | PDGFRA | 0.33878663 |
133 | ADRBK1 | 0.33789338 |
134 | PRKCA | 0.33686085 |
135 | STK3 | 0.33360021 |
136 | FGFR2 | 0.33090551 |
137 | IRAK1 | 0.32728733 |
138 | TSSK6 | 0.32131955 |
139 | PRKACB | 0.32047050 |
140 | PRKAA2 | 0.31904892 |
141 | PRKCZ | 0.31647780 |
142 | YES1 | 0.31439328 |
143 | KIT | 0.30130811 |
144 | NME1 | 0.29981159 |
145 | VRK1 | 0.28739798 |
146 | MELK | 0.28496201 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.14184641 |
2 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.78832983 |
3 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.74592059 |
4 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.74292027 |
5 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.63381273 |
6 | Olfactory transduction_Homo sapiens_hsa04740 | 2.56976003 |
7 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.32794103 |
8 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.22947307 |
9 | Circadian entrainment_Homo sapiens_hsa04713 | 2.22327710 |
10 | Morphine addiction_Homo sapiens_hsa05032 | 2.15284326 |
11 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.08773816 |
12 | Long-term potentiation_Homo sapiens_hsa04720 | 2.06529649 |
13 | ABC transporters_Homo sapiens_hsa02010 | 2.06349286 |
14 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.04804991 |
15 | GABAergic synapse_Homo sapiens_hsa04727 | 1.98408421 |
16 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.94625026 |
17 | Salivary secretion_Homo sapiens_hsa04970 | 1.90243293 |
18 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.86239316 |
19 | Taste transduction_Homo sapiens_hsa04742 | 1.75649657 |
20 | Renin secretion_Homo sapiens_hsa04924 | 1.74489549 |
21 | Insulin secretion_Homo sapiens_hsa04911 | 1.70323388 |
22 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.68929673 |
23 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.67152201 |
24 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.66845128 |
25 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.62820554 |
26 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.60628936 |
27 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.57900433 |
28 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.56039099 |
29 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.53965957 |
30 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.49895589 |
31 | Axon guidance_Homo sapiens_hsa04360 | 1.47103618 |
32 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.45509583 |
33 | Long-term depression_Homo sapiens_hsa04730 | 1.43756548 |
34 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.42155800 |
35 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.39914838 |
36 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.39505846 |
37 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.39473187 |
38 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.38578817 |
39 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.37600864 |
40 | Histidine metabolism_Homo sapiens_hsa00340 | 1.37169713 |
41 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.35821600 |
42 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.34775179 |
43 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.34580085 |
44 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.32442066 |
45 | Cocaine addiction_Homo sapiens_hsa05030 | 1.32413652 |
46 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.31611248 |
47 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.31239588 |
48 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.30971060 |
49 | Homologous recombination_Homo sapiens_hsa03440 | 1.29867327 |
50 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.24186492 |
51 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.23922222 |
52 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.21443285 |
53 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.10114576 |
54 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.08630298 |
55 | Gap junction_Homo sapiens_hsa04540 | 1.08410888 |
56 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.07719691 |
57 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.06488408 |
58 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.06102026 |
59 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.05101569 |
60 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.03553694 |
61 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.02597348 |
62 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.01787529 |
63 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.00631538 |
64 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.00275201 |
65 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.98003478 |
66 | Melanogenesis_Homo sapiens_hsa04916 | 0.96047411 |
67 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.94322021 |
68 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.94250771 |
69 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.93170908 |
70 | Retinol metabolism_Homo sapiens_hsa00830 | 0.92881889 |
71 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.91249088 |
72 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.90840058 |
73 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.88866422 |
74 | Glioma_Homo sapiens_hsa05214 | 0.88655724 |
75 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.87450353 |
76 | Basal transcription factors_Homo sapiens_hsa03022 | 0.86978915 |
77 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.85607748 |
78 | Circadian rhythm_Homo sapiens_hsa04710 | 0.84856123 |
79 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.84514552 |
80 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.84039426 |
81 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.81985934 |
82 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.81951588 |
83 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.81894047 |
84 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.81561108 |
85 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.79492894 |
86 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.78983414 |
87 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.78584493 |
88 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.78389559 |
89 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.78043879 |
90 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.77677083 |
91 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.77378235 |
92 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.75154476 |
93 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.74851693 |
94 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.74201318 |
95 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.68273192 |
96 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.67597933 |
97 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.67483634 |
98 | Peroxisome_Homo sapiens_hsa04146 | 0.66666145 |
99 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.65829032 |
100 | Parkinsons disease_Homo sapiens_hsa05012 | 0.65134118 |
101 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.64715969 |
102 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.63706661 |
103 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.63302545 |
104 | Adherens junction_Homo sapiens_hsa04520 | 0.61071299 |
105 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.60993128 |
106 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.60721674 |
107 | Prion diseases_Homo sapiens_hsa05020 | 0.59641283 |
108 | Bile secretion_Homo sapiens_hsa04976 | 0.59442915 |
109 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.59279708 |
110 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.58476812 |
111 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.58168261 |
112 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.57851619 |
113 | Lysosome_Homo sapiens_hsa04142 | 0.56655910 |
114 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.56566413 |
115 | Colorectal cancer_Homo sapiens_hsa05210 | 0.55767076 |
116 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.55217785 |
117 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.55034866 |
118 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.54322366 |
119 | Huntingtons disease_Homo sapiens_hsa05016 | 0.53963565 |
120 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.53107332 |
121 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.52294794 |
122 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.51794484 |
123 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.51670218 |
124 | Endocytosis_Homo sapiens_hsa04144 | 0.50618463 |
125 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.50496179 |
126 | Phototransduction_Homo sapiens_hsa04744 | 0.50148229 |
127 | Alzheimers disease_Homo sapiens_hsa05010 | 0.49230189 |
128 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.48343784 |
129 | Sulfur relay system_Homo sapiens_hsa04122 | 0.47588967 |
130 | Melanoma_Homo sapiens_hsa05218 | 0.47175909 |
131 | Endometrial cancer_Homo sapiens_hsa05213 | 0.47158583 |
132 | RNA polymerase_Homo sapiens_hsa03020 | 0.45891926 |
133 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.45568876 |
134 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.45287497 |
135 | Mineral absorption_Homo sapiens_hsa04978 | 0.45253618 |
136 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.44183687 |
137 | Platelet activation_Homo sapiens_hsa04611 | 0.43559091 |
138 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.42704114 |
139 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.42407249 |
140 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.42342315 |
141 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.42336881 |
142 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.41938034 |
143 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.40879029 |
144 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.40476558 |
145 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.39954763 |
146 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.39881511 |
147 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.39397047 |
148 | Asthma_Homo sapiens_hsa05310 | 0.38781281 |
149 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.35913650 |
150 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.35775074 |
151 | Lysine degradation_Homo sapiens_hsa00310 | 0.34836572 |
152 | Protein export_Homo sapiens_hsa03060 | 0.34047328 |
153 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.33978425 |
154 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.31187048 |